New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareNonapeptide-1 vs PGPIPN

Nonapeptide-1 vs PGPIPN

Side-by-side comparison of key properties, dosing, and research.

Skin & Cosmetic
Nonapeptide-1
Immune Support
PGPIPN
Summary
Nonapeptide-1 is a synthetic 9-amino acid peptide that inhibits melanin production by blocking α-MSH (alpha-melanocyte stimulating hormone) receptor binding. Used in cosmetic formulations for skin lightening and evening skin tone, it is particularly effective for UV-induced and hormonal hyperpigmentation.
PGPIPN is a bioactive hexapeptide (Pro-Gly-Pro-Ile-Pro-Asn) derived from beta-casein during enzymatic digestion. It exhibits anti-inflammatory properties via opioid receptor modulation and cytokine suppression, making it relevant for gut health, systemic inflammation, and as a component of casein-derived functional foods.
Half-Life
Not applicable (topical)
Estimated 30-120 minutes (peptide degradation)
Admin Route
Topical
Oral, Subcutaneous (research)
Research
Typical Dose
0.05–0.5% concentration in formulation
200-500 mg per day
Frequency
Twice daily
Once or twice daily
Key Benefits
  • Inhibits UV-induced tanning and hyperpigmentation
  • Reduces hormonal melasma
  • Evens skin tone at receptor level
  • Well-tolerated with minimal irritation
  • Complementary to tyrosinase inhibitors for enhanced brightening
  • Reduces post-inflammatory hyperpigmentation
  • Anti-inflammatory effects via cytokine suppression
  • Gut mucosal protection and intestinal barrier support
  • Opioid receptor modulation for gut motility regulation
  • Potential analgesic activity via central and peripheral opioid pathways
  • Explored for inflammatory bowel conditions and gut dysbiosis
  • Natural origin (food-derived) with favorable safety profile
Side Effects
  • Generally very well-tolerated
  • Rare contact sensitivity in susceptible individuals
  • Theoretical risk of excessive depigmentation with prolonged high-concentration use
  • Generally very well-tolerated given food-derived origin
  • Theoretical opioid-mediated constipation at high doses
  • Rare milk protein allergy in casein-sensitive individuals
Stacks With